Tumor- and host-related parameters could be calibrated using clinical measurements, such as, imaging-derived vascular permeability and tumor burden, biopsy-based immune profile (e.g., CD8+T and CAR-T cell infiltration), and circulating immune cells (e.g., CD8+T and CAR-T cells, and APC). Here, CD8A is linked to neoplasm.